The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of anti-PD-(L1) therapy in combination with chemotherapy versus immunotherapy (IO) alone for first-line (1L) treatment of advanced non-small cell lung cancer (NSCLC) with PD-L1 score 1-49%: FDA pooled analysis.
 
Oladimeji Akinboro
No Relationships to Disclose
 
Jonathon Joseph Vallejo
Employment - AstraZeneca (I)
 
Pallavi Shruti Mishra-Kalyani
No Relationships to Disclose
 
Erin A. Larkins
No Relationships to Disclose
 
Nicole Lauren Drezner
No Relationships to Disclose
 
Shenghui Tang
No Relationships to Disclose
 
Richard Pazdur
No Relationships to Disclose
 
Julia A. Beaver
No Relationships to Disclose
 
Harpreet Singh
No Relationships to Disclose